Imipenem/Cilastatin versus Cefepime as Empiric Monotherapy for Fever in Neutropenic Patients after ematopoietic Stem Cell Transplantation

Objective: To evaluate the potential advantages of imipenem/cilastatin in control of fever in neutro-penic HSCT recipients.Patients and Method: In this single-center study, 111 consecutive febrile episodes in 104 neutropenic HSCT recipients with a mean age of 26 years were randomized to treatment ei...

Celý popis

Podrobná bibliografie

Hlavní autoři:	C Kani, A Mousavi, M Iravani, K Alimoghaddam, B Bahar, M Jahani, A Ghavamzadeh
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Tehran University of Medical Sciences 2005-06-01
Edice:	International Journal of Hematology-Oncology and Stem Cell Research
Témata:	Febrile neutropenia Monotherapy Hematopoietic stem cell transplantation Randomized trial
On-line přístup:	https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/189
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!